Yayın: Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison
| dc.contributor.author | Ulviye Acar Çevik | |
| dc.contributor.author | ULVİYE, ACAR | |
| dc.contributor.author | Begüm Nurpelin Sağlık | |
| dc.contributor.author | OSMANİYE, DERYA | |
| dc.contributor.author | Derya Osmani̇ye | |
| dc.contributor.author | KARADUMAN, ABDULLAH BURAK | |
| dc.contributor.author | Serkan Levent | |
| dc.contributor.author | Özkay, Yusuf | |
| dc.contributor.author | Betül Kaya Çavuşoğlu | |
| dc.contributor.author | SAĞLIK ÖZKAN, BEGÜM NURPELİN | |
| dc.contributor.author | Abdullah Burak Karaduman | |
| dc.contributor.author | LEVENT, SERKAN | |
| dc.contributor.author | Özlem Atlı Ekliog̈lu | |
| dc.contributor.author | Yusuf Özkay | |
| dc.contributor.author | ATLI EKLİOĞLU, ÖZLEM | |
| dc.contributor.author | KAPLANCIKLI, ZAFER ASIM | |
| dc.contributor.author | Zafer Asım Kaplancıklı | |
| dc.contributor.orcid | 0000-0003-1879-1034 | |
| dc.contributor.orcid | 0000-0002-0151-6266 | |
| dc.contributor.orcid | 0000-0002-0499-436X | |
| dc.contributor.orcid | 0000-0003-3692-163X | |
| dc.contributor.orcid | 0000-0001-8270-4949 | |
| dc.contributor.orcid | 0000-0002-0434-1334 | |
| dc.contributor.orcid | 0000-0002-6131-3399 | |
| dc.contributor.orcid | 0000-0001-8815-153X | |
| dc.contributor.orcid | 0000-0003-2252-0923 | |
| dc.date.accessioned | 2025-11-13T09:30:56Z | |
| dc.date.issued | 2020-01-01 | |
| dc.identifier.doi | https://doi.org/10.1080/14756366.2020.1806831 | |
| dc.identifier.endpage | 1673 | |
| dc.identifier.issn | 1475-6366 | |
| dc.identifier.issue | 1 | |
| dc.identifier.openalex | W3056535081 | |
| dc.identifier.startpage | 1657 | |
| dc.identifier.uri | https://hdl.handle.net/11421/1361 | |
| dc.identifier.uri | https://doi.org/10.1080/14756366.2020.1806831 | |
| dc.identifier.volume | 35 | |
| dc.language.iso | en | |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | |
| dc.rights | openAccess | |
| dc.subject | HeLa | |
| dc.subject | Benzimidazole | |
| dc.subject | Topoisomerase | |
| dc.subject | Oxadiazole | |
| dc.subject | Chemistry | |
| dc.subject | Stereochemistry | |
| dc.subject | Docking (animal) | |
| dc.subject | Cell culture | |
| dc.subject | Doxorubicin | |
| dc.subject | Cytotoxicity | |
| dc.subject | In vitro | |
| dc.subject | Biochemistry | |
| dc.subject | Biology | |
| dc.subject | Organic chemistry | |
| dc.subject.sdg | 3 | |
| dc.title | Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| local.authorid.openalex | A5047270177 | |
| local.authorid.openalex | A5017640266 | |
| local.authorid.openalex | A5030295748 | |
| local.authorid.openalex | A5030511747 | |
| local.authorid.openalex | A5074136342 | |
| local.authorid.openalex | A5075534569 | |
| local.authorid.openalex | A5087171830 | |
| local.authorid.openalex | A5060247565 |
